logo.png
Publication of Annual Report 2020
March 30, 2021 01:00 ET | Acacia Pharma Group plc
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia Pharma Group plc Publishes its Annual Report and Financial...
logo.png
Results for the year ended 31 December 2020
March 29, 2021 01:00 ET | Acacia Pharma Group plc
  This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia Pharma Group plc Results for the year ended 31...
logo.png
Notice of Full Year 2020 Results
March 18, 2021 03:00 ET | Acacia Pharma Group plc
Acacia Pharma to Report its Results for the Full Year 2020 and Provide a Business Update on 29 March 2021              Cambridge, UK and Indianapolis, US – 18 March 2021, 08:00 CET: Acacia Pharma...
logo.png
Total Number of Voting Rights and Capital
March 11, 2021 12:00 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. Publication in application of Article 15 of the Law of 2 May 2007 (the Transparency Law) Acacia Pharma Group plc Cambridge, UK and Indianapolis, US –...
logo.png
Transparency Notification
March 05, 2021 03:05 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY 2007 ON THE DISCLOSURE OF MAJOR HOLDINGS) Acacia...
logo.png
Transparency Notification
February 26, 2021 02:00 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY 2007 ON THE DISCLOSURE OF MAJOR HOLDINGS) Acacia...
logo.png
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
February 26, 2021 02:00 ET | Acacia Pharma Group plc
Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Cambridge, UK and Indianapolis, US – 26 February 2021, 08:00 CET: Acacia Pharma Group plc (“Acacia...
logo.png
Admission to Trading on Euronext Brussels
February 23, 2021 02:00 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN...
logo.png
Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities
February 19, 2021 02:00 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR...
logo.png
Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS®
February 18, 2021 07:15 ET | Acacia Pharma Group plc
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION...